fluorodeoxyglucose f18 has been researched along with Bile Duct Cancer in 107 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (2.80) | 18.2507 |
| 2000's | 27 (25.23) | 29.6817 |
| 2010's | 52 (48.60) | 24.3611 |
| 2020's | 25 (23.36) | 2.80 |
| Authors | Studies |
|---|---|
| Doroudinia, A; Ghadimi, N; Karam, MB; Yousefi, F | 1 |
| Chiti, A; Costa, G; Fiz, F; Ieva, F; Masci, C; Sollini, M; Torzilli, G; Viganò, L | 1 |
| Harada, M; Otomi, Y; Otsuka, H; Shinya, T; Shono, N | 1 |
| Halanaik, D; Meenakshi, LA; Pottakkat, B; Rajaraman, V; Selvaraj, AJ | 1 |
| Mori, Y; Novruzov, E; Novruzov, F | 1 |
| Abe, O; Akamatsu, N; Hasegawa, K; Hinata, M; Kanemaru, N; Nakai, Y; Nakao, T; Nakazawa, A; Ushiku, T; Watadani, T | 1 |
| Al-Ibraheem, A; Al-Qasem, S; Amarin, R; El Khaldi, M | 1 |
| Abbey, L; Abdelghany, TM; Abdellatif, MH; Abdelmohsen, UR; Abduljaleel Alzawar, NS; Abid, MF; Abu Kasim, AFB; Abu Saad, H; Adolpho, LF; Agostini, F; Agrizii, AP; Ahmed, S; Akce, M; Åkesson, D; Al-Awaadh, AM; Al-Mutar, DMK; Al-Odayni, AB; Al-Rajhi, AMH; Alaaeldin, R; Alam, M; Alam, MM; Alanazi, MA; Alattar, H; Alawlaqi, MM; Aldebis, HK; Algehainy, NA; Almeida, AA; Aloisi, F; Alrahlah, A; Alsenani, F; Alshabib, A; Altemani, FH; Althagafi, A; Amari, A; Andronesi, AG; Antonyuk, M; Arantes, TD; Araújo, R; Arrotti, S; Asakura, T; Asib, N; Atlaskin, AA; Aung, MS; Axiaq, A; Azekawa, S; Bacon, S; Bagalagel, A; Balbinot, GS; Barnet, LS; Baroyi, SAHM; Barreto, F; Barth, Y; Barysheva, AV; Bassa, E; Basu, R; Basu, S; Bates, C; Bautista, LS; Beitl, K; Beloti, MM; Benatti, G; Benavent-Celma, C; Bentaher, A; Bergsland, N; Bernardino, AF; Bernhardt, A; Bhandari, RK; Bhaskaran, K; Bhate, K; Bhattacharjee, A; Bian, X; Bien, EM; Birch, M; Bishara, K; Biswas, JP; Bleha, R; Bocale, R; Bona, S; Boriani, G; Bouyssi, A; Bradley, D; Bravo-Sánchez, MG; Bressan, GC; Brik, A; Brizuela, A; Brockbank, KGM; Buchner, F; Bunc, M; Buscombe, JR; Butler, AJ; Buzaleh, AM; Buzin, MI; Cabrera-Capetillo, CA; Calvo, AM; Camerota, A; Campagna, G; Campisi, M; Cano, K; Cao, HST; Cardellini, S; Carvalho, AP; Carvalho, BCR; Castillo-Baltazar, OS; Cataldo, P; Chai, P; Chakraborty, S; Chalo, DM; Chan, MY; Chander, S; Changbunjong, T; Chappuis, CJF; Chee, RCH; Chen, C; Chen, CJ; Chen, E; Chen, M; Chen, X; Chen, Y; Cheng, HT; Cheng, MC; Cheow, HK; Chi, Y; Chirikova, NK; Chiu, SH; Cho, G; Cho, HR; Cho, S; Cho, SJ; Choe, A; Choe, YH; Chun, BS; Chun, Z; Cinque, A; Ciopec, M; Cladas, Y; Cleary, SP; Clermont, O; Cléroux, M; Cockburn, J; Collares, FM; Colombini-Ishikiriama, BL; Conn, BN; Cortina, JL; Cox, DRA; Crini, G; Croker, R; Cursaru, DL; Curtis, HJ; da Silva, KJG; Dalla Costa, T; Davy, S; de Araújo, BV; de Cassia Ribeiro Gonçalves, R; de Gaetano, F; de Gregorio, C; de Oliveira, MG; De Vera, MAT; de Vos, M; de-la-Fuente, I; Dell'Oca, I; Delles, M; Déméautis, T; Dempster, M; Deng, YH; Denisenko, Y; Descombes, C; Desideri, G; Devarbhavi, H; Devouassoux, G; Di Bella, G; Di Marco, F; Diao, Y; Dias, BB; Dilgin, Y; Dimopoulou, I; Dionísio, TJ; Dobrovic, A; Dokin, ES; Dolby, T; Dong, X; Dong, Y; Dou, SX; Douglas, IJ; Dousset, S; Du, Z; Duan, M; Duan, SB; Duke-Williams, O; Duteanu, N; Dutertre, S; Dutta, S; Dwyer, MG; Ebenbauer, J; Eggo, RM; El-Mordy, FMA; Elbhnsawi, NA; Elrehany, MA; Elshewemi, SS; Elwakil, BH; Emadzadeh, D; Eraso, E; Ermolenko, E; Erten, K; Ettorre, E; Evans, D; Evans, SJ; Faheem, M; Fallanza, M; Faramarzi, M; Faria, FAC; Faro, DC; Fatma, YS; Fazil, S; Feng, Y; Ferguson, J; Fernandes, MH; Fernández-Domínguez, M; Ferrari, LAL; Ferraz, EP; Ferreira, LC; Ferri, C; Fikry, M; Floris, M; Forbes, H; Fotouh, B; Franke, K; Freitas, AC; Freitas, GP; Frieboes, HB; Fu, B; Fu, Y; Fukina, DG; Fukuda, DH; Fukunaga, K; Fulham, GJ; Furlan, L; Furtado Mesa, M; Furtunescu, FL; Gabbieri, D; Ganash, M; Gebers, JC; Gehman, V; Ghaedi, A; Ghazali, NSM; Ghebrekristos, Y; Gil, J; Gilbert, NM; Gimenes, R; Giordano, L; Glehen, O; Godeau, C; Goh, SK; Goldacre, B; Gomes, AM; Gomes, MPO; Gomes, PS; Gomes, RMODS; Gómez-Coma, L; Grenho, L; Gu, Q; Gu, T; Gu, YC; Guiducci, V; Guillemin, JP; Guo, W; Guo, YW; Gur, E; Guridi, A; Guzmán-López, A; Gvozdenko, T; H Elmaidomy, A; Hagar, M; Haider, S; Han, JM; Hanratty, J; Hans, R; Haque, N; Harharah, HN; Harharah, RH; Harper, S; Hasegawa, N; Hassanin, AH; Hastuti, YP; Hatem, AE; He, R; He, Y; Heinemann, C; Heinmaa, I; Heinzl, F; Helfer, VE; Hester, F; Hickman, G; Hill, MA; Hill, WG; Hintze, V; Ho, JSY; Ho, LY; Hoang, T; Holzer, I; Houbraken, J; Hsu, CN; Hu, J; Hu, X; Hu, Y; Hua, T; Huang, Z; Hulme, WJ; Hunter, A; Ianăşi, C; Ibañez, R; Iezzi, R; Iliuță, L; Im, YM; Imran, M; Inglesby, P; Inguimbert, N; Iqbal, A; Izawa, N; Jahaj, E; Jain, S; Jakimovski, D; Jalal, MM; Jaroszuk-Ściseł, J; Jasim, DJ; Jauregizar, N; Javle, MM; Jędryczka, M; Ji, H; Jiang, Y; Jin, J; Johnson, NT; Joshi, S; Jullok, N; Kachapulula, PW; Kaczmarek, J; Kaczmarek-Szczepańska, B; Kadota, K; Kaji, M; Kakeji, Y; Kakizoe, S; Kakudidi, E; Kalitukha, L; Kamata, H; Kang, YJ; Kapinos, AA; Karakaya, S; Kashchenko, NI; Kasyanov, S; Kataky, R; Katati, B; Kato, G; Katsina, AU; Kaya, A; Kaya, H; Kazarina, OV; Ke, Y; Keenan, C; Keilson, JM; Keshavan, A; Keskinidou, C; Khalifa, MA; Khan, R; Khan, S; Kim, D; Kim, K; Kim, MS; Kim, SM; Kim, WH; Kim, Y; Kim, YJ; Kishimura, H; Kitagawa, RR; Klemenkova, ZS; Kloss, F; Kobayashi, N; Kohlhoff, M; Kong, WKF; Konsek, H; Kornaros, M; Kotanidou, A; Kovacs, S; Kraska, J; Kruppke, B; Kumagai, Y; Kumar, S; Kumari, R; Kuruva, V; Kuster, RM; Kusumoto, T; Kutyła, M; Kwon, JH; Kwon, SH; Kwong, KY; Kyser, AJ; Lackner, M; Lass-Flörl, C; Lauri, C; Lavandera, JV; Lee, BH; Lee, ECY; Lee, HJ; Lee, J; Lee, PS; Lee, S; Lee, SE; Lee, SY; Lefort, F; Leite, JPV; Leo, G; Leonard, R; Leow, AST; Lepori, N; Leyden, K; Leys, L; Ležaić, L; Li, D; Li, H; Li, J; Li, S; Li, TYW; Li, X; Li, XH; Li, Y; Li, Z; Li, ZH; Liao, S; Liaqat, K; Lim, H; Lin, BS; Lin, MY; Lin, NH; Lin, X; Lin, Y; Liu, C; Liu, H; Liu, HK; Liu, HX; Liu, P; Liu, R; Liu, T; Liu, X; Liu, Y; Lock, GA; Lokaj, G; Lopes, HB; Losi, V; Lotsios, NS; Low, KE; Lu, Z; Luhana, S; Luo, X; Luo, XQ; Lutz, MB; Lysova, AA; Lyssenko, KA; Macit, M; MacIver, B; MacKenna, B; Magalhães, GAP; Magnavacchi, P; Mahadevan, J; Mahboubi, A; Maher, SA; Mahipal, A; Mahmoud, MY; Maithel, SK; Makhtar, MMZ; Makurat-Kasprolewicz, B; Malysheva, YB; Mansourizadeh, A; Marek, EJ; Maresca-Fichter, H; Martin, JT; Maslov, AA; Mastora, Z; Mastroiacovo, D; Mastropetros, SG; Matei, D; Mathur, R; Matos, AO; Matsuda, Y; Maurya, SK; Mayor, Á; Mayrhofer, D; Mazzuco, AC; McCaffrey, J; McClure, T; McDonald, HI; Mchunu, NP; McLaggan, D; Mehrkar, A; Meilik, B; Melito, VA; Mellem, J; Mengozzi, A; Menotti, J; Mesquita, V; Miao, Z; Mihai, S; Miller, S; Minassian, C; Mirabile, A; Mitra, S; Mladin, G; Mo, Z; Moawad, H; Mohamed, EM; Mohammed, TJ; Mohanlall, V; Mohyeldin, RH; Moldovan, H; Monneret, G; Monopoli, DE; Monte, IP; Monteiro, JRB; Morgante, V; Mori, M; Morin-Crini, N; Morita, A; Morton, CE; Mrak, M; Muhammed, AP; Mulick, A; Muralidharan, V; Murthy, P; Muselli, M; Mustafa, S; Mysore Visweswariah, A; Nagao, G; Naicker, S; Nakagawara, K; Namgoong, B; Namkoong, H; Namukobe, J; Nasir, AA; Nasreen, SA; Natarajan, P; Nchiozem-Ngnitedem, VA; Necozione, S; Negrea, A; Negrea, P; Ngubane, S; Nguyen, TT; Nicke, A; Nightingale, E; Nistor, CL; Nitsch, D; Njapau, H; Noman, M; Novgorodtseva, T; Nowak, A; O'Connor, SR; Ofoe, R; Oh, K; Oh, TH; Oki, E; Olama, ZA; Olennikov, DN; Oliveira, GM; Omar, D; Ong, SJ; Orfanos, SE; Origa-Oryem, H; Orita, H; Ortiz, I; Ota, M; Ott, J; Otvagina, KV; Pacheco, N; Pacheco, RR; Padmanabhan, D; Pagan, JD; Pagnotta, PA; Palangi, V; Palanisamy, G; Palanisamy, K; Palanisamy, S; Pan, SG; Panaitescu, E; Pang, X; Panoutsakopoulos, V; Parera, VE; Park, JI; Park, JS; Park, SW; Park, Y; Park, YS; Parkash, O; Parry, J; Parry, JP; Paul, SK; Pavšič, N; Pałubicka, A; Persat, F; Petriz-Prieto, MA; Petukhov, AN; Pham, T; Pillay, S; Poh, KK; Ponomarev, II; Pontons-Melo, JC; Posa, A; Powell, E; Priya, AK; Punekar, R; Puppin Rontani, RM; Purushottam, M; Pusphanathan, K; Qi, JY; Qin, J; Qin, Z; Qiu, B; Qiu, X; Quattrini, G; Quindós, G; Qureshi, F; Rabbany, MA; Rac-Albu, M; Rac-Albu, ME; Rădulescu, BC; Rafatullah, M; Rajab, TK; Rajna, S; Ramanathan, M; Rao, D; Raviglione, D; Razorenov, DY; Redd, MJ; Rehman, W; Reig, M; Rentsch, CT; Ribeiro, LMS; Robles, D; Rocchi, S; Rocha, FG; Rodrigues, C; Rodrigues, LA; Rodrigues, RP; Roh, GH; Ronowska, A; Root, A; Rosa, AL; Rossi, R; Roy, S; Roy, VC; Rupji, M; Saber, EA; Sadarat, F; Saed, Y; Saeed, WS; Saeki, H; Saha, B; Saiwichai, T; Sakowicz-Burkiewicz, M; Sampedro, T; Sands, K; Santos, CF; Sari, M; Sathi, FA; Sauro, S; Sazanova, TS; Scafa-Udriște, A; Schoustra, SE; Schultze, A; Seo, DJ; Sevillano, E; Sezmis, G; Sgura, FA; Shah, NNAK; Shani, N; Shankarappa, B; Sharkey, LM; Sharma, VK; Sharp, C; Shehata, N; Shelton, N; Shieh, PB; Shimokawa, M; Shin, J; Shin, SH; Shin, YN; Shin, YR; Shipilova, A; Shoparwe, NF; Shukor, H; Sia, CH; Siddiqui, MH; Siddiqui, MR; Siena, V; Signore, A; Silwane, B; Siqueira-Sandrin, VS; Siregar, A; Sirignano, P; Sit, NW; Skidmore, S; Skupov, KM; Smeeth, L; Smoczer, C; Smolyanskiy, E; Sohn, H; Solodeev, I; Solovyev, A; Şomoghi, R; Song, F; Song, H; Song, Z; Souf, YM; Sousa, SC; Souza, MT; Steinbach-Rankins, JM; Stockton, J; Stout, JR; Su, K; Su, MZ; Suarez-Lopez, YA; Sukkurd, R; Sultanov, R; Sun, Y; Sun, Z; Supernak, M; Supriyono, E; Suroshe, SS; Suvorov, SS; Svera M Ianăşi, P; Switchenko, JM; Syarif, NY; Synytsya, A; Taherzadeh, MJ; Tain, YL; Tamburino, C; Tammam, OY; Tan, BYQ; Tan, H; Tan, S; Tanaka, H; Tang, R; Tang, X; Tang, Z; Taurino, M; Tazare, J; Teresi, L; Testro, A; Thanasoponkul, W; Thangarasu, S; Thavaselvam, D; Theodoro, RC; Theron, G; Thomas, RH; Thomson, JJ; Tian, X; Tian, Y; Tomaszewski, CA; Tomlinson, LA; Torres, CMME; Tóth, M; Trecourt, A; Trevisani, F; Trimarchi, G; Tristán, C; Truong, VK; Tsigkou, K; Tsutsumi, S; Ubukata, Y; Uehara, H; Uwamino, Y; Vahedi-Shahandashti, R; Valberg, SJ; Valderrama, C; Valdovinos-García, EM; Valsecchi, D; van Diepeningen, AD; van West, P; Vargas-Osuna, E; Vassall, M; Vassilaki, N; Vassiliou, AG; Vecino, X; Velez-Irizarry, D; Venkatesh, YN; Vignali, L; Virdis, A; Viswanath, B; Voisin, AS; Volkova, YA; Vorotyntsev, AV; Vorotyntsev, IV; Vtyurina, ES; Vu, DH; Waldridge, B; Walker, AJ; Wallon, M; Wang, B; Wang, G; Wang, H; Wang, J; Wang, LJ; Wang, S; Wang, T; Wang, X; Wang, Z; Warren, RM; Warren-Gash, C; Wei, SH; Weinstock-Guttman, B; Wekwejt, M; Wessjohann, LA; Wiesmann, HP; Williams, ZJ; Williamson, EJ; Wilson, M; Wing, K; Wong, AY; Wong, BKL; Woodward, S; Wozniak, KL; Wu, C; Wu, K; Wu, S; Wu, Y; Xiang, D; Xie, H; Xiong, X; Xu, C; Xu, H; Xu, J; Xu, WH; Xu, Y; Xun, T; Yamaguchi, S; Yan, P; Yan, W; Yan, Z; Yang, B; Yang, F; Yang, L; Yao, XB; Yasui, H; Yenesew, A; Yeo, LLL; Yeo, TC; Yi, S; Yin, F; Yip, JWL; Yoon, SH; Yoon, SJ; Yoshida, M; Yoshizumi, T; Young, LA; Yu, C; Yu, DD; Yu, F; Yu, H; Yu, JD; Yu, NJ; Yu, X; Yuan, Y; Yurenko, A; Yusof, YA; Zahedipoor, A; Zahran, EM; Zainuddin, NI; Zanatta, AC; Zanotto, ED; Zanozin, ID; Zavascki, AP; Zenke, M; Zhang, F; Zhang, G; Zhang, H; Zhang, J; Zhang, L; Zhang, MX; Zhang, NY; Zhang, Q; Zhang, W; Zhang, X; Zhang, XM; Zhao, F; Zhao, Q; Zhao, R; Zhao, Y; Zheng, J; Zheng, S; Zhou, L; Zhou, X; Zhu, H; Zivadinov, R; Žižek, D; Zuccoli, JR; Zwaan, BJ | 1 |
| Abdlkadir, AS; Al-Ibraheem, A; Alalawi, H; Badarneh, M | 1 |
| Amorim, BJ; Bernstine, HH; Blaszkowsky, LS; Canamaque, LG; Catalano, OA; Catana, C; Collazo, YQ; Domachevsky, L; Duenas, VP; Ferrone, C; Gervais, D; Goyal, L; Groshar, D; Herrmann, K; Hong, TS; Li, Y; Mahmood, U; Pandharipande, PV; Qadan, M; Rosen, BR; Sahani, DV; Shih, TT; Tanabe, KK; Umutlu, L; Vangel, M; Wo, JY; Zhu, AX | 1 |
| Bagni, O; Cianni, R; Di Costanzo, GG; Filippi, L; Marino Marsilia, G; Pelle, G; Saltarelli, A; Schillaci, O; Tortora, R | 1 |
| Balcı, C; Çelebi, F; Cindil, E; Dogusoy, GB; Tokat, Y; Yaghouti, K | 1 |
| Gabata, T; Harada, K; Inoue, D; Kinuya, S; Kitao, A; Kobayashi, S; Koda, W; Kozaka, K; Matsui, O; Ohta, T; Sato, Y; Tajima, H; Takamura, H; Yoneda, N | 1 |
| Chen, H; Hao, B; Pang, Y; Shang, Q; Sun, L | 1 |
| Duzenli, T; Koseoglu, H | 1 |
| Kim, HJ; Kim, NH; Kim, YH; Lee, SR | 1 |
| Ruan, J; Tu, J; Tu, Z; Yang, Y | 1 |
| Huang, X; Li, J; Xiong, Y; Yang, J | 1 |
| Dang, H; Huang, X; Liu, H; Ning, J; Wu, Y; Xu, B | 1 |
| Choi, SY; Ha, SY; Hwang, JA; Hyun, SH; Kim, HS; Kim, SH; Kim, SW; Min, JH | 1 |
| Guniganti, P; Kierans, AS | 1 |
| Bo, X; Chen, L; Liu, G; Liu, H; Pang, L; Shi, H; Wang, C; Wang, J; Wang, Y; Yu, H | 1 |
| Hwang, JP; Kim, HK; Lee, MH; Lim, CH; Moon, JH; Park, JM; Park, SB; Yoon, JK | 1 |
| Filizoglu, N; Oksuzoglu, K; Ozguven, S | 1 |
| Ding, H; Geist, BK; Hacker, M; Huo, L; Li, F; Li, X; Liu, B; Shao, Y; Wang, J; Wang, X; Zhang, H; Zhao, H | 1 |
| Chan, ACY; Cheung, TT; Chiu, WH; Chok, KSH; Dai, WC; Lo, CM; Ma, KW; She, WH | 1 |
| Chu, YY; Hu, JH; Lin, CH; Liu, NJ; Tang, JH | 1 |
| Fukuhara, H; Ishitobi, H; Kobayashi, Y; Komazawa, Y; Kuroda, H; Nagaoka, M; Sato, S; Shizuku, T; Takahashi, Y; Yuki, M | 1 |
| Blake, J; Pissanou, T; Reilly, MM; Rossor, AM | 1 |
| Bagnato, A; Calabria, FF; Leporace, M | 1 |
| Bian, Y; Hu, Y; Tian, C; Wei, Q; Wu, D | 1 |
| Fuji, H; Ikeno, Y; Nakamoto, Y; Seo, S; Taura, K; Uemoto, S; Uemoto, Y; Yamamoto, G; Yoh, T; Yoshino, K | 1 |
| Gámez-Cenzano, C; Gràcia-Sánchez, L; Lladó, L; Mestres-Martí, J; Ramos, E; Reynés-Llompart, G; Robles, J; Sabaté-Llobera, A; Serrano, T | 1 |
| Aota, T; Arimoto, A; Hamano, G; Ito, T; Kinoshita, M; Koda, M; Kubo, S; Nakamori, S; Nakanuma, Y; Sato, Y; Shinkawa, H; Takemura, S; Tanaka, S; Toyokawa, H; Yamamoto, T | 1 |
| Chen, Y; Fang, C; Liu, H; Zhang, W | 1 |
| Fuji, H; Higashi, T; Ikeno, Y; Ishii, T; Kaido, T; Morino, K; Nakamoto, Y; Seo, S; Taura, K; Uemoto, S; Yoh, T | 1 |
| Kubo, S; Tanaka, S | 1 |
| Cho, YS; Choi, JY; Hyun, SH; Lee, KH; Lim, CH; Moon, SH | 1 |
| Okano, K; Oshima, M; Suzuki, Y; Yachida, S; Yamamoto, N | 1 |
| Cho, YK; Jeon, WK; Ju, DY; Kim, BI; Kim, HJ; Lee, JY; Park, DI; Park, JH; Shin, DS; Sohn, CI; Yim, SH; Yu, JH | 1 |
| Kim, DU; Kim, H; Kim, IJ; Kim, K; Kim, SJ; Pak, K | 1 |
| Cheon, GJ; Choe, JG; Kim, DS; Oh, SY; Park, BJ; Park, TG; Yu, YD | 1 |
| Lee, SM; Park, MS | 1 |
| Kang, HC; Kim, HK; Kim, SJ; Kim, SS; Oak, CY; Yoon, JH | 1 |
| Annunziata, S; Caldarella, C; Galiandro, F; Giovanella, L; Pizzuto, DA; Sadeghi, R; Treglia, G | 1 |
| Bergquist, A; Karlson, BM; Rasmussen, I; Rorsman, F; Sangfelt, P; Sundin, A; Wanders, A | 1 |
| Camacho, JC; Kim, HS; Kokabi, N; Schuster, DM; Xing, M | 1 |
| Bagni, O; Cianni, R; Filippi, L; Pelle, G; Scopinaro, F | 1 |
| Cho, YH; Choi, GS; Choi, HJ; Choi, MH; Chung, JC; Jang, JY; Jeong, SW; Jin, SJ; Kim, BS; Kim, DC; Kim, HS; Kim, SG; Kim, YS; Lee, MH; Lee, SH; Lee, YN; Moon, JH; Park, JM; Song, JY | 1 |
| Jeon, TJ; Kim, JK; Lee, JH; Oh, EJ; Park, JS; Ryu, YH; Yoo, JS; Yoon, DS; Yoon, SO | 1 |
| Bhasin, D; Bhattacharya, A; Gupta, R; Kang, M; Kapoor, R; Mittal, BR; Rana, S; Santhosh, S | 1 |
| Baek, HW; Cho, S; Lee, DS; Lee, K; Lee, KH; Park, H; Park, JK; Suh, KJ | 1 |
| Araki, K; Bolog, A; Komuta, M; Kubo, N; Kuwano, H; Suzuki, H; Tsukagoshi, M; Wada, S; Watanabe, A; Yokobori, T | 1 |
| Bryant, R; Burge, ME; Cavallucci, D; Eastgate, M; Finch, R; Francesconi, A; Hopkins, G; Houston, K; Macfarlane, D; O'Rourke, N; Thomas, P; Wyld, D | 1 |
| Marcus, C; Parikh, U; Sarangi, R; Subramaniam, RM; Taghipour, M | 1 |
| Jiang, L; Panje, CM; Shi, H; Tan, H; Xiu, Y; Yu, H | 1 |
| Hirayama, K; Karbwang, J; Matsuda, N; Na-Bangchang, K; Plengsuriyakarn, T; Viyanant, V | 1 |
| Chang, SH; Cheon, YK; Chung, HW; Lee, EJ; Lee, TY; Shim, CS; So, Y; Yoon, SY | 1 |
| Cheng, W; Jing, H; Li, Y; Shao, H; Yu, L | 1 |
| Chiba, T; Haga, H; Hatano, E; Isoda, H; Kodama, Y; Kurita, A; Kuriyama, K; Minamiguchi, S; Nakamoto, Y; Sawai, Y; Togashi, K; Uemoto, S; Uza, N; Yoshimura, K | 1 |
| Alvarenga, RP; Canedo, NH; Chimelli, L; de Almeida, SA; Ferreira, CG; Schmidt, GJ; Schmidt, JJ; Schmidt, SL; Simoes, EN; Tolentino, JC | 1 |
| Feng, F; Huo, L; Jin, Z; Li, F; Liao, Q; Zhao, Y | 1 |
| Asakura-Yokoe, K; Furukawa, H; Ikuma, H; Uesaka, K | 1 |
| Doi, R; Hatano, E; Higashi, T; Ikai, I; Iwaisako, K; Mori, A; Nakajima, A; Nakamoto, Y; Seo, S; Tada, M; Tamaki, N; Uemoto, S | 1 |
| Antoch, G; Broelsch, CE; Gerken, G; Grabellus, F; Kaiser, GM; Kuehl, H; Li, J; Müller, SP; Nadalin, S; Paul, A; Radunz, S | 1 |
| Arita, H; Fujita, S; Futami, S; Kawai, K; Kiyohara, S; Nagamachi, S; Nishii, R; Tamura, S; Wakamatsu, H | 1 |
| Gottschild, D; Kornberg, A; Küpper, B; Sappler, A; Thrum, K; Wilberg, J | 1 |
| Bang, S; Chung, JB; Moon, CM | 1 |
| Joo, SY; Ko, HM; Lee, BK; Lee, NH; Seo, YH | 1 |
| Cho, YK; Jeon, WK; Kim, BI; Kim, HJ; Lee, SW; Park, DI; Park, JH; Sohn, CI | 1 |
| Fujishima, F; Fukuda, H; Hayashi, H; Hiraide, T; Kaneta, T; Takahashi, S; Takanami, K; Unno, M; Yamada, S | 1 |
| Anthony, MP; Khong, PL; Mak, H | 1 |
| Doi, R; Hatano, E; Higashi, T; Ikai, I; Kitamura, K; Nakamoto, Y; Narita, M; Nitta, T; Seo, S; Taura, K; Uemoto, S; Yamanaka, K; Yasuchika, K | 1 |
| Dittmar, Y; Götz, M; Heise, M; Rauchfuss, F; Scheuerlein, H; Settmacher, U; Voigt, R | 1 |
| Jang, JY; Kim, BS; Kim, SG; Kim, YS; Koh, ES; Lee, MS; Moon, JH; Park, JM; Park, SK | 1 |
| Bartenstein, P; Bruns, CJ; Hacker, M; Haug, AR; Heinemann, V; Hoffmann, R; Jakobs, T | 1 |
| Bennink, RJ; Busch, OR; Engelbrecht, MR; Gouma, DJ; Ruys, AT; van Gulik, TM; van Westreenen, HL | 1 |
| Mudun, A; Ozkan, G; Sanli, Y; Turkmen, C; Yegen, G | 1 |
| Chatburn, L; Mercier, G; Peller, PJ; Sacks, A; Subramaniam, RM; Surasi, DS | 1 |
| Bonomo, L; Castaldi, P; De Gaetano, AM; Filograna, L; Gatto, AM; Giordano, A; Rufini, V | 1 |
| Dong, A; Dong, H; Zhang, L; Zuo, C | 1 |
| Gu, XJ; Liu, R; Wang, BF | 1 |
| Knox, JJ; Zhu, AX | 1 |
| Choi, EK; Choi, WH; Kim, SH; Na, SJ; O, JH; Park, SY; Yoo, IeR | 1 |
| Asaka, M; Kato, T; Katoh, C; Kondo, S; Kuge, Y; Nambu, T; Nobuta, A; Tamaki, N; Tsukamoto, E | 1 |
| Kim, KS; Kim, YJ; Lee, JD; Lee, WJ; Yun, M | 1 |
| Anderson, CD; Chapman, WC; Chari, RS; Delbeke, D; Pinson, CW; Rice, MH | 1 |
| Berr, F; Caca, K; Kluge, R; Mössner, J; Müller, D; Sabri, O; Wiedmann, M | 1 |
| Biersack, HJ; Bucerius, J; Dumoulin, FL; Gerhardt, T; Jaeger, U; Reinhardt, MJ; Roedel, R; Sauerbruch, T; Strunk, H | 1 |
| Sugano, K; Tamada, K | 1 |
| Brambs, HJ; Juchems, MS; Pauls, S | 1 |
| Ahn, YH; Cho, AE; Choi, CW; Choi, JS; Han, KH; Im, SS; Kim, HM; Kim, KS; Kim, TS; Ko, D; Lee, JD; Park, JH; Park, YN; Yang, WI; Yun, M | 1 |
| Bissoli, S; Chierichetti, F; Fiore, V; Liessi, G; Pasquali, C; Pedrazzoli, S; Sperti, C | 1 |
| Baba, H; Chikamoto, A; Kanemitsu, K; Takamori, H; Tsuji, T; Uozumi, H; Yamashita, Y | 1 |
| Bourguet, P; Metges, JP; Mitry, E; Monteil, J; Planchamp, F; Tubiana-Mathieu, N | 1 |
| Bang, S; Chung, JB; Lee, JD; Moon, CM; Park, SW; Song, SY; Yun, M | 1 |
| Akhurst, T; Blumgart, LH; Corvera, CU; D'Angelica, M; DeMatteo, RP; Fong, Y; Jarnagin, WR | 1 |
| Hwang, CY; Kim, JS; Kim, JY; Kim, MH; Lee, SK; Lee, SS; Lee, TY; Seo, DW; Yun, SC | 1 |
| Endo, K; Higuchi, T; Nakajima, T; Oriuchi, N; Paudyal, B; Paudyal, P | 1 |
| Buchmann, I; Ganten, TM; Haberkorn, U | 1 |
| Fujimori, T; Iso, Y; Kubota, K; Murakami, K; Sawada, T; Shimoda, M; Tomita, S | 1 |
| Dahlerup, JF; Gee, A; Hansen, SB; Keiding, S; Kruse, A; Rasmussen, HH; Roelsgaard, K; Tage-Jensen, U | 2 |
| Fukuda, T; Jomura, H; Kawabe, J; Kawashima, D; Koyama, K; Kuroki, T; Ochi, H; Sasaki, N; Shiomi, S | 1 |
| Graz, KF; Manns, MP; Meier, PN; Mix, H; Petrich, T; van den Hoff, J; Wagner, S; Widjaja, A | 1 |
| Barthel, H; Berr, F; Caca, K; Georgi, P; Hesse, S; Huster, D; Kluge, R; Schmidt, F; Seese, A | 1 |
| Bohuslavizki, KH; Broering, DC; Buchert, R; Clausen, M; Fritscher-Ravens, A; Jenicke, L; Rogiers, X; Schäfer, H | 1 |
13 review(s) available for fluorodeoxyglucose f18 and Bile Duct Cancer
| Article | Year |
|---|---|
The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fatty Liver; Fibroblasts; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
Multimodal imaging findings of intrahepatic cholangiocarcinoma arising from a biliary adenofibroma: a case report with radiological-pathological correlation.
Topics: Adenofibroma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Middle Aged; Multimodal Imaging | 2023 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: A meta-analysis.
Topics: Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
PET/MRI of the hepatobiliary system: Review of techniques and applications.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis.
Topics: Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Odds Ratio; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Preoperative Care; Publication Bias; ROC Curve | 2018 |
Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in the evaluation of the primary tumor in patients with cholangiocarcinoma: a meta-analysis.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2014 |
FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes.
Topics: Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Liver Neoplasms; Male; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
The role of (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis, staging, and follow-up of cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Value of PET/CT in the management of primary hepatobiliary tumors, part 2.
Topics: Acetates; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Liver Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.
Topics: Adenocarcinoma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
[Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)].
Topics: Anus Neoplasms; Bile Duct Neoplasms; Colorectal Neoplasms; Digestive System Neoplasms; Endocrine Gland Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Intestine, Large; Liver Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2007 |
[[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Liver Neoplasms; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
6 trial(s) available for fluorodeoxyglucose f18 and Bile Duct Cancer
| Article | Year |
|---|---|
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Preoperative staging of biliary carcinoma using 18F-fluorodeoxyglucose PET: prospective comparison with PET+CT, MDCT and histopathology.
Topics: Bile Duct Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma.
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed | 2008 |
Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Detection of Klatskin's tumor in extrahepatic bile duct strictures using delayed 18F-FDG PET/CT: preliminary results for 22 patient studies.
Topics: Adult; Aged; Bile Duct Neoplasms; Female; Fluorodeoxyglucose F18; Hepatic Duct, Common; Humans; Image Interpretation, Computer-Assisted; Klatskin Tumor; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
89 other study(ies) available for fluorodeoxyglucose f18 and Bile Duct Cancer
| Article | Year |
|---|---|
Steatotic Hepatitis Presenting as a Huge Hypermetabolic Liver Mass.
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Young Adult | 2022 |
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Multicystic Biliary Hamartoma With Xanthogranulomatous Inflammation on 18F-FDG PET/CT.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cysts; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Hamartoma; Humans; Inflammation; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography | 2022 |
Role of 68 Ga-FAPI PET/CT in Assessing Hepatobiliary Malignancies : A Prospective Pilot Study.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Pilot Projects; Positron Emission Tomography Computed Tomography; Prospective Studies | 2023 |
68 Ga-FAPI PET/CT Provides a Clear Picture of a Klatskin Tumor That 18 F-FDG PET/CT Missed.
Topics: Bile Duct Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Klatskin Tumor; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
68 Ga-FAPI PET/CT Imaging : Unveiling the Hidden Pitfalls.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography | 2023 |
Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
Prognostic value of neutrophil-to-lymphocyte ratio and its correlation with fluorine-18-fluorodeoxyglucose metabolic parameters in intrahepatic cholangiocarcinoma submitted to 90Y-radioembolization.
Topics: Adult; Aged; Bile Duct Neoplasms; Cell Count; Cholangiocarcinoma; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Lymphocytes; Male; Middle Aged; Neutrophils; Positron Emission Tomography Computed Tomography; Prognosis; Yttrium Radioisotopes | 2020 |
The Role of 18F-FDG PET/MRI in the Assessment of Primary Intrahepatic Neoplasms.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Differences in 18F-FDG Uptake and Expression of Glucose Transporter Between 2 Distinct Subtypes of Mass-Forming Intrahepatic Cholangiocarcinomas.
Topics: Aged; Bile Duct Neoplasms; Biological Transport; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transport Proteins, Facilitative; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2020 |
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in a Patient With Cholangiocellular Carcinoma: A Case Report.
Topics: Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Quinolines | 2020 |
Predictive role of neutrophil to lymphocyte ratio in patients with intrahepatic cholangiocarcinoma submitted to treatment of 90Y-microspheres.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Lymphocytes; Microspheres; Neutrophils; Prognosis; Yttrium Radioisotopes | 2020 |
Diagnostic Performance and Prognostic Relevance of FDG Positron Emission Tomography/Computed Tomography for Patients with Extrahepatic Cholangiocarcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Survival Rate; Tomography, X-Ray Computed | 2020 |
FDG PET/CT Findings in Biliary Papillomatosis.
Topics: Bile Duct Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Grading; Papilloma; Positron Emission Tomography Computed Tomography | 2020 |
[18F]-FDG PET/CT in a case of metastatic extrahepatic bile duct cancer from sigmoid carcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Carcinoma; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Contrast Media; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2021 |
Role of dual-time point
Topics: Bile Duct Neoplasms; Fluorodeoxyglucose F18; Humans; Klatskin Tumor; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2021 |
Prognostic value of metabolic parameters measured by pretreatment dual-time-point 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with intrahepatic or perihilar cholangiocarcinoma: A STROBE study.
Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Klatskin Tumor; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2021 |
Primary Adenosquamous Carcinoma of the Liver on FDG PET/CT.
Topics: Aged; Bile Duct Neoplasms; Carcinoma, Adenosquamous; Female; Fluorodeoxyglucose F18; Humans; Liver; Positron Emission Tomography Computed Tomography | 2021 |
Dynamic
Topics: Adult; Aged; Aorta, Thoracic; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Hepatic Artery; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Common Bile Duct; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gallbladder Neoplasms; Humans; Klatskin Tumor; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2018 |
Intrahepatic Cholangiolocellular and Cholangiocellular Carcinoma - Differences in the
Topics: Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Rectal Neoplasms; Tomography, Spiral Computed | 2017 |
Sensory neuronopathy associated with cholangiocarcinoma diagnosed 6 years after symptom onset.
Topics: Bile Duct Neoplasms; Cholangiocarcinoma; Delayed Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Nervous System Diseases; Neural Conduction; Outcome Assessment, Health Care; Positron-Emission Tomography; Sensation Disorders; Time Factors; Wheelchairs | 2017 |
Situs Inversus Totalis and Cholangiocarcinoma of the Gallbladder Detected by 18F-FDG PET/CT.
Topics: Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Situs Inversus | 2018 |
Three Primary Carcinomas on 18F-FDG PET/CT: Intrahepatic Cholangiocarcinoma, Papillary Renal Cell Carcinoma, and Clear Cell Renal Cell Carcinoma.
Topics: Aged; Bile Duct Neoplasms; Carcinoma, Renal Cell; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Usefulness of Preoperative
Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Papillary; Cholangiocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Preoperative Period; ROC Curve | 2018 |
Differences on metabolic behavior between intra and extrahepatic cholangiocarcinomas at
Topics: Aged; Bile Duct Neoplasms; Biomarkers, Tumor; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2019 |
The Clinical Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Occupational\
Cholangiocarcinoma
Topics: Adult; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Occupational Diseases; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2018 |
FDG PET/CT Imaging of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus.
Topics: Bile Duct Neoplasms; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Thrombosis | 2019 |
Reappraisal of Prognostic Impact of Tumor SUVmax by
Topics: Adult; Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals | 2019 |
Programmed death-1 inhibitor for occupational intrahepatic cholangiocarcinoma caused by chlorinated organic solvents.
Topics: Adult; Antineoplastic Agents, Immunological; Bile Duct Neoplasms; Biomarkers, Tumor; Chlorine Compounds; Cholangiocarcinoma; Fluorodeoxyglucose F18; Hepatectomy; Humans; Male; Nivolumab; Occupational Exposure; Positron-Emission Tomography; Radiopharmaceuticals; Solvents | 2019 |
Prognostic value of
Topics: Adult; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2019 |
Education and imaging. Hepatobiliary and pancreatic: intrahepatic biliary cystadenocarcinoma.
Topics: Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cystadenocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2013 |
Primary tumor maximum standardized uptake value measured on 18F-fluorodeoxyglucose positron emission tomography-computed tomography is a prognostic value for survival in bile duct and gallbladder cancer.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Splenic FDG uptake predicts poor prognosis in patients with unresectable cholangiocarcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Risk Assessment; Sensitivity and Specificity; Spleen; Survival Rate | 2014 |
Implication of lymph node metastasis detected on 18F-FDG PET/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Diffuse metastasis to the thyroid: unique ultrasonographic finding and clinical correlation.
Topics: Aged; Bile Duct Neoplasms; Biopsy, Fine-Needle; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Hypothyroidism; Lung Neoplasms; Male; Middle Aged; Penile Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Function Tests; Thyroid Gland; Thyroid Neoplasms; Ultrasonography | 2014 |
Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangitis, Sclerosing; Constriction, Pathologic; Cytological Techniques; Disease Progression; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Transplantation; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity | 2014 |
PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic cholangiocarcinoma.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2014 |
Change in total lesion glycolysis and clinical outcome after (90)Y radioembolization in intrahepatic cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
Topics: Adult; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Preoperative Period; Prognosis; Recurrence; Retrospective Studies | 2015 |
Analysis of the roles of glucose transporter 1 and hexokinase 2 in the metabolism of glucose by extrahepatic bile duct cancer cells.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Hexokinase; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Diagnostic accuracy of F-18 FDG PET/CECT vs. CECT for detecting recurrence of periampullary carcinoma and its prognostic significance.
Topics: Bile Duct Neoplasms; Bile Ducts; Carcinoma; Cholangiography; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiographic Image Enhancement; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Dermatomyositis in a Patient with Cholangiocarcinoma Detected by an [(18)F]-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scan.
Topics: Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Dermatomyositis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Paraneoplastic Syndromes; Positron Emission Tomography Computed Tomography | 2016 |
Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma.
Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Male; Middle Aged; Positron-Emission Tomography; Pyruvate Kinase; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2015 |
A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Queensland; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Klatskin Tumor; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Anticancer Activity of Atractylodes lancea (Thunb.) DC in a Hamster Model and Application of PET-CT for Early Detection and Monitoring Progression of Cholangiocarcinoma.
Topics: Animals; Atractylodes; Bile Duct Neoplasms; Cholangiocarcinoma; Cricetinae; Disease Progression; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Male; Mesocricetus; Multimodal Imaging; Phytotherapy; Plant Extracts; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Prognostic Value of FDG-PET/CT Total Lesion Glycolysis for Patients with Resectable Distal Bile Duct Adenocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Use of 18F-FDG PET Scan and Ultrasound-guided Biopsy in the Diagnosis of Hepatic Carcinomas.
Topics: Adult; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Image-Guided Biopsy; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2015 |
Impact of EUS-FNA for preoperative para-aortic lymph node staging in patients with pancreatobiliary cancer.
Topics: Adult; Aged; Aged, 80 and over; Ampulla of Vater; Aorta; Bile Duct Neoplasms; Carcinoma; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Common Bile Duct Neoplasms; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2016 |
Cholangiocarcinoma associated with limbic encephalitis and early cerebral abnormalities detected by 2-deoxy-2-[fluorine-18]fluoro-D-glucose integrated with computed tomography-positron emission tomography: a case report.
Topics: Aged; Bile Duct Neoplasms; Brain; Brain Diseases; Cholangiocarcinoma; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Limbic Encephalitis; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Intraductal Papillary Mucinous Neoplasm of the Pancreas With High Malignant Potential on FDG PET/MRI.
Topics: Bile Duct Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Papillary; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Usefulness of a deep-inspiration breath-hold 18F-FDG PET/CT technique in diagnosing liver, bile duct, and pancreas tumors.
Topics: Adult; Aged; Bile Duct Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inhalation; Lung Neoplasms; Male; Middle Aged; Movement; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Recurrence-free long-term survival after liver transplantation in patients with 18F-FDG non-avid hilar cholangiocarcinoma on PET.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Risk Factors; Survival Rate | 2009 |
[Cholangiocarcinoma with distant cutaneous metastases].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2009 |
Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
FDG PET/CT findings in malignant intraductal papillary mucinous neoplasm of the bile ducts.
Topics: Bile Duct Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Papilloma, Intraductal; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
An unusual case of synchronous renal cell carcinoma in a horseshoe kidney and intrahepatic cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Carcinoma, Renal Cell; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Male; Radionuclide Imaging; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with extrahepatic bile duct cancer.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate | 2011 |
[Hepatocellular carcinoma and cholangiocarcinoma].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biopsy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Combined Modality Therapy; Contrast Media; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Detection of distant metastasis to skeletal muscle by 18F-FDG-PET in a case of intrahepatic cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2010 |
18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Serum Albumin; Survival Analysis; Technetium Tc 99m Aggregated Albumin; Tin Compounds; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2011 |
FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Netherlands; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Metastasis of malignant melanoma to common biliary duct demonstrated with F-18 FDG PET/CT.
Topics: Bile Duct Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
F-18 FDG uptake in borderline intraductal papillary neoplasms of the bile duct.
Topics: Aged; Bile Duct Neoplasms; Biological Transport; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
[Application of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of hilar cholangiocarcinoma].
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues.
Topics: Adenocarcinoma; Adult; alpha-Fetoproteins; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers; Biopsy; CA-125 Antigen; Capecitabine; Carcinoembryonic Antigen; Carrier Proteins; CDX2 Transcription Factor; Chemotherapy, Adjuvant; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Cytokines; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Gemcitabine; Glycoproteins; Hepatectomy; Homeodomain Proteins; Humans; Immunohistochemistry; Keratin-20; Keratins; Liver; Liver Neoplasms; Lymph Node Excision; Magnetic Resonance Imaging; Membrane Transport Proteins; Phenotype; Portal Vein; Pregnancy; Receptors, Estrogen; Receptors, Progesterone | 2012 |
The clinical value of dual-time point 18F-FDG PET/CT for differentiating extrahepatic cholangiocarcinoma from benign disease.
Topics: Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2013 |
Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma.
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
[Is 18F-FDG-PET suitable for therapy monitoring after palliative photodynamic therapy of non-resectable hilar cholangiocarcinoma?].
Topics: Bile Duct Neoplasms; Cholestasis, Intrahepatic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematoporphyrin Photoradiation; Hepatic Duct, Common; Humans; Klatskin Tumor; Male; Neoplasm Staging; Outcome Assessment, Health Care; Ovarian Neoplasms; Palliative Care; Peritoneal Neoplasms; Positron-Emission Tomography; Prospective Studies | 2005 |
[Diagnosis and treatment of bile duct cancer--from the viewpoint of physician].
Topics: Bile Duct Neoplasms; Bile Ducts; Cholangiopancreatography, Endoscopic Retrograde; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Photochemotherapy; Positron-Emission Tomography; Stents; Tomography, X-Ray Computed; Ultrasonography | 2005 |
[Radiological diagnosis of Klatskin's tumour].
Topics: Bile Duct Neoplasms; Cholangiopancreatography, Magnetic Resonance; Fluorodeoxyglucose F18; Hepatic Duct, Common; Humans; Klatskin Tumor; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 2005 |
Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Cells, Cultured | 2005 |
Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms.
Topics: Adult; Aged; Aged, 80 and over; Ampulla of Vater; Bile Duct Neoplasms; Duodenal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Laparotomy; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Risk Assessment; Sensitivity and Specificity | 2006 |
The diagnostic efficacy of FDG-PET in the local recurrence of hilar bile duct cancer.
Topics: Aged; Bile Duct Neoplasms; Cholangitis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatic Duct, Common; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2008 |
18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholecystectomy; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2008 |
Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Bile Ducts, Intrahepatic; Biopsy; Cholangiocarcinoma; Cholangiopancreatography, Magnetic Resonance; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Magnetic Resonance Angiography; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Hexokinase; Humans; Immunohistochemistry; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Middle bile duct cancer with portal vein tumor thrombus.
Topics: Aged; Bile Duct Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplastic Cells, Circulating; Portal Vein; Positron-Emission Tomography; Venous Thrombosis | 2008 |
Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangitis, Sclerosing; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Tomography, Emission-Computed | 1998 |
Combined hepatocellular carcinoma and cholangiocarcinoma with high F-18 fluorodeoxyglucose positron emission tomographic uptake.
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Positron emission tomography and cholangiocarcinoma in primary sclerosing cholangitis.
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangitis, Sclerosing; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
[Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangitis, Sclerosing; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Tomography, Emission-Computed | 2000 |
Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Diseases; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Radiography; Radiopharmaceuticals; Reference Values; ROC Curve; Tomography, Emission-Computed | 2001 |
FDG PET in the diagnosis of hilar cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 2001 |